Followers | 229 |
Posts | 14659 |
Boards Moderated | 1 |
Alias Born | 03/29/2014 |
![](https://investorshub.advfn.com/uicon/467032.png?cb=1478627184)
Monday, January 23, 2017 2:00:45 PM
https://www.sec.gov/Archives/edgar/data/1072379/000114420417003329/v457335_ex99-1.htm
LP is a master manipulator, and is king of the castle and is everything to this company, she wears all the hats. It is no wonder if she is out the company basically shuts down. You can say the same about Trump. - Al4door
Well I’m not sure the company exactly shuts down when LP gets sick as it seems LG is still hard at work… but LP does wear a lot of hats. And under her watch, she has come up with some fairly brilliant strategies to move the company forward… despite the fact that our share price has moved back (a lot).
Under her watch, she took the P2 to a P3 trial. She took the treatment to Europe and the UK. She took Direct to inoperable tumors. She's expanded the manufacturing of DCVax to be ready for commercialization. I’m sure I’m forgetting a few but those have been some of her bigger moves. Hopefully we find out soon if those strategic moves pay off.
Now the next question is… what is the move she’s making with regulators to move forward the trial with a treatment where everyone is living longer, but where PFS might be compromised? What is it that she could do on this account to improve share holder value… while remaining silent about it?
This latest 8-k makes it clear they are awaiting information from an independent CRO and independent imaging company - while NWBO remains blinded. Wouldn’t that already have been looked at when the patient evented? What could they do with the MRIs now that haven’t already been done?
The good thing is that answers are forthcoming - sometime soon?
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM